InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 142127

Tuesday, 09/24/2013 6:40:25 PM

Tuesday, September 24, 2013 6:40:25 PM

Post# of 346631
Peregrine listed as "Supporter Level" IASLC

Don’t miss the great opportunity to market to one of the largest international gatherings of researchers, clinicians and professionals in the lung cancer and thoracic oncology field. The 15th World Conference on Lung Cancer will bring together leaders in the field of thoracic oncology from across the world. As a Sponsor your team will have the opportunity to network with these valuable contacts, providing a unique opportunity for your organization to gain widespread exposure to Australian, Asian and international markets.

http://wclc.iaslc.org/sponsorship-exhibits/sponsorship.html

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News